Success Metrics

Clinical Success Rate
87.5%

Based on 70 completed trials

Completion Rate
88%(70/80)
Active Trials
12(9%)
Results Posted
29%(20 trials)
Terminated
10(7%)

Phase Distribution

Ph phase_3
11
8%
Ph early_phase_1
8
6%
Ph phase_1
22
16%
Ph phase_2
38
28%
Ph phase_4
10
7%
Ph not_applicable
47
35%

Phase Distribution

30

Early Stage

38

Mid Stage

21

Late Stage

Phase Distribution136 total trials
Early Phase 1First-in-human
8(5.9%)
Phase 1Safety & dosage
22(16.2%)
Phase 2Efficacy & side effects
38(27.9%)
Phase 3Large-scale testing
11(8.1%)
Phase 4Post-market surveillance
10(7.4%)
N/ANon-phased studies
47(34.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.3%

70 of 93 finished

Non-Completion Rate

24.7%

23 ended early

Currently Active

12

trials recruiting

Total Trials

136

all time

Status Distribution
Active(17)
Completed(70)
Terminated(23)
Other(26)

Detailed Status

Completed70
unknown26
Withdrawn13
Terminated10
Recruiting9
Not yet recruiting4

Development Timeline

Analytics

Development Status

Total Trials
136
Active
12
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 18 (5.9%)
Phase 122 (16.2%)
Phase 238 (27.9%)
Phase 311 (8.1%)
Phase 410 (7.4%)
N/A47 (34.6%)

Trials by Status

completed7051%
not_yet_recruiting43%
terminated107%
unknown2619%
withdrawn1310%
enrolling_by_invitation11%
recruiting97%
active_not_recruiting32%

Recent Activity

Clinical Trials (136)

Showing 20 of 136 trialsScroll for more
NCT03865992Not Applicable

Curcumin in Reducing Joint Pain in Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint Disease

Active Not Recruiting
NCT07785986Not Applicable

Curcumin Versus Ibuprofen for Exercise-Induced Muscle Damage in Physically Active Women

Completed
NCT07436130Not Applicable

Curcumin in Critically Ill Patients With Sepsis

Recruiting
NCT02782949Phase 2

Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia

Active Not Recruiting
NCT01543386Phase 1

Effects of Curcumin on Vascular Reactivity

Completed
NCT03935958Not Applicable

Curcumin in Kidney Transplant Recipients

Active Not Recruiting
NCT05377242Not Applicable

Curcumin, Resveratrol, and Stinging Nettle as Treatments for GWI

Completed
NCT03769766Phase 3

Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance

Recruiting
NCT06053411Early Phase 1

Contribution of UGT2B17 to the Pharmacokinetics of Diclofenac

Recruiting
NCT02255370Phase 3

Curcumin Associated With Thiopurin in the Prevention of Post-op Recurrence in Crohn Disease

Completed
NCT07251985Phase 2

Cognitive Effects of Bioavailable Curcumin

Withdrawn
NCT07523256Not Applicable

Effect of Curcumin Add-On Therapy on Quality of Life and IL-1β Levels in Patients With Schizophrenia

Completed
NCT02064673Phase 3

Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy

Recruiting
NCT02724202Early Phase 1

Curcumin in Combination With 5FU for Colon Cancer

Terminated
NCT07379177Not Applicable

Evaluation of the Pharmacokinetics of Curcumin Capsules in Healthy Human

Not Yet Recruiting
NCT02554344Early Phase 1

Effect of Curcumin in Treatment of Squamous Cervical Intraepithelial Neoplasias (CINs)

Withdrawn
NCT06359665Phase 1

Oral Curcumin for the Treatment of Pain of Thumb Base Joint (CMC) Arthritis

Enrolling By Invitation
NCT06055894Not Applicable

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

Recruiting
NCT05062486Phase 2

A Study to Evaluate the Safety and Efficacy of RQC for AMD

Completed
NCT06458465Not Applicable

Impact of Curcumin and Pentoxiphylline on Chronic Kidney Disease Patients

Completed

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
136